Peer Review
Cancer Imaging
ISSN 1470-7330
Search site with:PicoSearch


Content
Current Issue
Archive
Related Journals / Articles
Information
Aims and Scope
Editors and Board
Editorial Policy
Instructions for Authors
Copyright Transfer Form
Subscription Information
Advertising
Society
Aims
Membership
Annual Meeting
Communications
Bulletin Board
Send Email to ICIS
e-Med
Visit e-Med Web Site
Journals
Purchase
“To Promote Education in Cancer Imaging in the Multidisciplinary Management of Malignancy”

Home > Articles

Cancer imaging: is it cost-effective?

Abstract

With expenditure on imaging patients with cancer set to increase in line with rising cancer prevalence, there is aneed to demonstrate the cost-effectiveness of advanced cancer imaging techniques. Cost-effectiveness studies aim to quantify the cost of providing a service relative to the amount of desirable outcome gained, such as improvements in patient survival. Yet, the impact of imaging on the survival of patients with cancer is small compared to the impact of treatment and is therefore hard to measure directly. Hence, techniques such as decision-tree analysis, that model the impact of imaging on survival, are increasingly used for cost-effectiveness evaluations. Using such techniques, imaging strategies that utilise computed tomography, magnetic resonance imaging and positron emission tomography have been shown to be more cost-effective than non-imaging approaches for the management of certain cancers including lung, prostate and lymphoma. There is stronger evidence to support the cost-effectiveness of advanced cancer imaging for diagnosis, staging and monitoring therapy than for screening. The results of cost-effectiveness evaluations are not directly transferable between countries or tumour types and hence more studies are needed. As many of the techniques developed to assess the evidence base for therapeutic modalities are not readily applicable to diagnostic tests, cancer imaging specialists need to define the methods for health technology assessment that are most appropriate to their speciality.

Author

K A Miles

Contact Details

Corresponding address:
Division of Clinical and Laboratory Sciences,
Brighton & Sussex Medical School, University of Sussex,
Falmer, Brighton BN1 9PX,
UK.

Reference

ICIS Cancer Imaging volume 4
DOI: 10.1102/1470-7330.2004.0017

Date Posted

6 April 2004


Screen PDF

Size

313.33 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):

1 second

ADSL 512Kb/s (Broadband):

4 seconds

64 Kb/s (ISDN):

39 seconds

33.3 Kb/s (Typical Modem):

1 minute 15 seconds

Print PDF

Size

190.41 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):

1 second

ADSL 512Kb/s (Broadband):

2 seconds

64 Kb/s (ISDN):

23 seconds

33.3 Kb/s (Typical Modem):

45 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 61053, London, SE16 7YZ. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.

© 2000-2009 International Cancer Imaging Society